血糖试纸市场规模、份额及成长分析（按应用、最终用途、技术及地区划分）－2026-2033年产业预测

预计到 2024 年，血糖试纸市场规模将达到 23.5 亿美元，到 2025 年将达到 25.7 亿美元，到 2033 年将达到 52.8 亿美元，在预测期（2026-2033 年）内，复合年增长率为 9.4%。

血糖试纸市场是医疗保健领域的重要组成部分，对有效管理糖尿病至关重要。随着全球糖尿病盛行率的上升，对血糖试纸的需求持续成长。成年糖尿病患者人数的显着增加凸显了定期血糖监测的必要性。近年来，监测技术正朝着更先进的方向发展，例如持续血糖监测（CGM）系统，该系统可提供即时数据，并最大限度地减少对传统试纸的依赖。然而，即使CGM设备的普及率不断提高，血糖值试纸仍因其价格实惠、易于使用而成为自我管理的首选，确保其在任何糖尿病护理策略中都扮演着不可或缺的角色。

血糖试纸市场驱动因素

受糖尿病管理意识的提高和医疗保健投入的增加，血糖试纸市场正经历显着增长。随着越来越多人意识到糖尿病管理的重要性，血糖值监测设备的普及率也随之提高。此外，世界各地的医疗机构和政府都将糖尿病的早期发现和有效管理列为优先事项。这项措施提高了血糖值试纸的可及性和使用率，随着越来越多的人寻求积极主动的措施来维护自身健康，从而促进了整个市场的扩张。

限制血糖试纸市场发展的因素

由于其他血糖监测技术的兴起，尤其是持续血糖监测（CGM）系统的出现，传统血糖试纸市场面临严峻的挑战。这些先进的系统能够即时提供血糖值读数，无需频繁进行指尖采血，为使用者提供了更便利、更人性化的血糖值监测方式。随着消费者越来越多地转向这些创新解决方案，对传统血糖试纸的需求可能会下降。这种转变表明，人们越来越倾向于选择更全面的血糖管理方案，从长远来看，这可能会对传统血糖试纸市场产生负面影响。

血糖试纸市场趋势

血糖试纸市场正呈现出显着的成长趋势，这主要得益于消费者对高效且便利的血糖监测解决方案日益增长的需求，而这又源于持续血糖监测（CGM）系统的广泛应用。这些先进技术利用皮下感测器提供即时血糖值追踪，显着减少了对传统指尖采血的依赖。随着消费者越来越重视易用且精准的健康管理工具，CGM系统凭藉其持续监测和改善血糖值管理的能力，正逐渐成为首选。这种转变不仅简化了检测流程，还有助于改善健康状况。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球血糖试纸市场规模（按应用领域及复合年增长率划分）（2026-2033 年）

• 1型
• 2型糖尿病
• 妊娠糖尿病
• 糖尿病前期

全球血糖试纸市场规模（按最终用途和复合年增长率划分）（2026-2033 年）

• 个人
• 医院和诊所
• 其他的

全球血糖试纸市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 葡萄糖去氢酵素（GDH）
• 葡萄糖氧化酵素
• 其他的

全球血糖试纸市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（USA）
• Eurofins Scientific（Luxembourg）
• Qiagen NV（Netherlands）
• Fujifilm Holdings Corporation（Japan）
• DiaSorin SpA（Italy）
• Bio-Rad Laboratories, Inc.（USA）
• Sekisui Medical Corporation（Japan）
• Ortho Clinical Diagnostics（USA）
• Beckman Coulter, Inc.（USA）
• Myriad Genetics, Inc.（USA）
• Alere Inc.（USA）
• Quest Diagnostics Incorporated（USA）
• LabCorp（USA）
• BioMerieux SA（France）
• ARUP Laboratories（USA）
• MSD（Merck & Co., Inc.）（USA）

结论与建议

Blood Glucose Test Strips Market size was valued at USD 2.35 Billion in 2024 and is poised to grow from USD 2.57 Billion in 2025 to USD 5.28 Billion by 2033, growing at a CAGR of 9.4% during the forecast period (2026-2033).

The blood glucose test strips market is a crucial segment in the healthcare sector, essential for effective diabetes management. With the increasing prevalence of diabetes globally, the demand for these test strips continues to grow. A significant rise in the adult population affected by diabetes underscores the necessity for regular blood glucose monitoring. Recent trends indicate a shift towards advanced monitoring technologies, such as continuous glucose monitoring (CGM) systems, which provide real-time data and minimize the reliance on traditional test strips. However, despite the emerging popularity of CGM devices, blood glucose test strips maintain their status as the favored option for self-monitoring due to their affordability and ease of use, ensuring they remain integral to diabetes care strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Blood Glucose Test Strips market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Blood Glucose Test Strips Market Segments Analysis

Global Blood Glucose Test Strips Market is segmented by Application, End Use, Technology And Region. Based on Application, the market is segmented into diabetes. Based on End Use, the market is segmented into individuals, hospitals and clinics and others. Based on Technology, the market is segmented into glucose dehydrogenase (GDH), glucose oxidase and others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Blood Glucose Test Strips Market

The blood glucose test strips market is experiencing notable growth driven by heightened awareness of diabetes management and rising healthcare investment. As more individuals recognize the importance of managing diabetes, there is a corresponding increase in the adoption of glucose monitoring devices. Additionally, healthcare organizations and governments around the globe are prioritizing the early detection and efficient management of diabetes. This focus has resulted in improved access to and utilization of blood glucose test strips, contributing to the overall expansion of this market as more people seek proactive measures to maintain their health and well-being.

Restraints in the Blood Glucose Test Strips Market

The blood glucose test strips market faces significant challenges due to the emergence of alternative glucose monitoring technologies, especially continuous glucose monitoring (CGM) systems. These advanced systems provide instant glucose readings while eliminating the need for regular fingerstick tests, thereby offering users a more convenient and user-friendly approach to monitoring their glucose levels. As consumers increasingly gravitate towards these innovative solutions, the demand for traditional blood glucose test strips may diminish. This shift highlights the growing preference for comprehensive glucose management options, which could adversely impact the market for conventional test strips in the long run.

Market Trends of the Blood Glucose Test Strips Market

The blood glucose test strips market is witnessing a notable trend towards the growing demand for efficient and convenient glucose monitoring solutions, particularly driven by the rise of continuous glucose monitoring (CGM) systems. These advanced technologies leverage subcutaneous sensors to provide real-time glucose level tracking, significantly reducing the reliance on traditional fingerstick tests. As consumers increasingly prioritize user-friendly and accurate health management tools, CGM systems are emerging as a preferred choice due to their ability to facilitate continuous monitoring and enhance management of blood sugar levels. This shift not only streamlines the testing process but also promotes better health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Blood Glucose Test Strips Market Size by Application & CAGR (2026-2033)

• Market Overview
• Type 1
• Type 2
• Gestational Diabetes
• Pre-Diabetes

Global Blood Glucose Test Strips Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Individuals
• Hospitals And Clinics
• Others

Global Blood Glucose Test Strips Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Glucose Dehydrogenase (GDH)
• Glucose Oxidase
• Others

Global Blood Glucose Test Strips Market Size & CAGR (2026-2033)

• North America (Application, End Use, Technology)
  • USA
  • Canada
• Europe (Application, End Use, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, End Use, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, End Use, Technology)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, End Use, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Medical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARUP Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD (Merck & Co., Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations